Member Detail - DF/HCC

Dr. Meghan J Mooradian, MD

Claim this profile

Massachusetts General Hospital Cancer Center

Studies Melanoma
Studies Lung Cancer
5 reported clinical trials
9 drugs studied

Area of expertise

1

Melanoma

Meghan J Mooradian, MD has run 4 trials for Melanoma. Some of their research focus areas include:

Stage IV
Stage III
2

Lung Cancer

Meghan J Mooradian, MD has run 2 trials for Lung Cancer. Some of their research focus areas include:

Stage IV

Affiliated Hospitals

Image of trial facility.

Massachusetts General Hospital Cancer Center

Image of trial facility.

Massachusetts General Hospital

Clinical Trials Meghan J Mooradian, MD is currently running

More about Meghan J Mooradian, MD

Clinical Trial Related

2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Meghan J Mooradian, MD has experience with

  • Cryoablation
  • Ipilimumab
  • Nivolumab
  • Evaluation Of CtDNA
  • Core Needle Biopsy
  • Pembrolizumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Meghan J Mooradian, MD specialize in?

Is Meghan J Mooradian, MD currently recruiting for clinical trials?

Are there any treatments that Meghan J Mooradian, MD has studied deeply?

What is the best way to schedule an appointment with Meghan J Mooradian, MD?

What is the office address of Meghan J Mooradian, MD?

Is there any support for travel costs?